Jobs / United States / Astrazeneca Pharmaceuticals Lp
Associate Director, Global Product Planner - Cell Therapy
Astrazeneca Pharmaceuticals Lp · 🇺🇸 US – Tarzana – CA
Sponsorship verdict
Sponsorship possible
One solid signal, not two — worth applying, and worth asking about sponsorship early.
- Employer is on a government sponsor recordThe US Department of Labor certified 99 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 31 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
- The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
- No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.
- What Astrazeneca Pharmaceuticals Lp paid sponsored hires in similar roles1 certified filing for “Global Product Teams Finance Director, R&D Finance” (Financial Managers) in MD: $196k–$196k, median $196k. Source: US Department of Labor LCA disclosure data (Oct 2025 – Jun 2026).
- Confirmed live todayWhen a source last listed this job as open.
US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).
A verdict summarises public evidence; it is not legal advice and never a guarantee — the employer and the immigration authority decide. Sign in to factor in where you can already work.
Or apply yourself on the official page →
Sponsor Radar — Astrazeneca Pharmaceuticals Lp
The US Department of Labor certified 99 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 31 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
Past sponsorship or register membership never guarantees sponsorship for this vacancy or for you. Full Sponsor Radar for Astrazeneca Pharmaceuticals Lp →
About the role
AstraZeneca is pioneering the next generation of medicines through innovative cell therapies that have the potential to transform the lives of patients with serious diseases. As a Global Product Planner , you will play a pivotal role in turning scientific innovation into reliable patient supply. You will shape the integrated supply chain strategy for a portfolio of autologous, allogeneic, and/or in vivo cell therapy products in clinical development. By connecting CMC Program Strategy, Clinical Operations, Technical Operations, and Supply Chain, you will translate ambitious development plans into clear, executable supply strategies that bring the right product to the right patient at the right time. Working at the forefront of a rapidly evolving field, you will navigate complex supply networks, anticipate challenges, align critical resources, and enable confident decision-making across the organization. Your expertise, collaboration, and leadership will help accelerate the development of transformative therapies and contribute to AstraZeneca’s ambition to improve outcomes for patients around the world. This role can be based in either Tarzana, CA, or Gaithersburg, MD. Key Responsibilities • Integrated End-to-End Planning: Maintain the integrated supply chain planning view for assigned cell therapy products, connecting CMC development strategy, clinical plans, technical operations, manufacturing, and logistics. Ensure alignment of drug substance, drug product, raw materials, production activities, and distribution across the end-to-end supply chain. • Supply Planning and Continuity: Translate CMC and clinical development plans into operational supply plans and forecasts. Determine study product requirements and proactively address supply risks to support continuous patient supply while balancing capacity, lead times, inventory, cost, and flexibility. • Scenario and Risk Planning: Build and maintain detailed supply models for complex clinical and CMC scenarios. Assess operational feasibility, identify constraints and dependencies, evaluate alternative strategies, and provide clear recommendations for risk mitigation and decision-making. • Clinical Supply and Operations Planning: Lead the product-level S&OP process, reviewing demand, supply, capacity, inventory, risks, and assumptions. Facilitate cross-functional decisions and escalate trade-offs requiring leadership alignment. • Supply Chain Configuration: Own and maintain the product supply chain configuration and value stream map, including planning parameters, lead times, production steps, suppliers, logistics routes, capacity assumptions, site dependencies, and CMO relationships. • Product and Supply Chain Leadership: Serve as the primary supply chain planning liaison across Clinical Operations, CMC Program Strategy, Technical Operations, and other key functions. Lead the relevant supply chain subteam, establish effective ways of working, and ensure that decisions, risks, assumptions, actions, and timelines are clearly communicated and executed. • Launch and Change Management: Lead the global supply planning response to product and network changes, including new indications, country expansion, CMC activities, manufacturing changes, site transfers, supplier changes, process changes, and other development or supply chain initiatives. • Stakeholder and Partner Collaboration: Build strong working relationships with internal stakeholders, manufacturing sites, CMOs, suppliers, logistics providers, and other external partners. Align stakeholders on supply requirements, constraints, risks, and mitigation plans. • Systems, Data, and Process Improvement: Support the development and adoption of planning systems, advanced digital technologies and AI, master data, and s